Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/03/2023 | 0.48% | Barclays | $18 → $19 | Maintains | Equal-Weight |
07/24/2023 | 11.05% | RBC Capital | $20 → $21 | Maintains | Outperform |
07/10/2023 | 21.63% | Citigroup | $22 → $23 | Maintains | Buy |
07/03/2023 | 21.63% | B of A Securities | $19 → $23 | Maintains | Buy |
07/03/2023 | 16.34% | HC Wainwright & Co. | → $22 | Reiterates | Buy → Buy |
05/30/2023 | 5.76% | Morgan Stanley | → $20 | Assumes | → Equal-Weight |
05/19/2023 | 16.34% | HC Wainwright & Co. | $19 → $22 | Maintains | Buy |
05/05/2023 | 0.48% | HC Wainwright & Co. | $21 → $19 | Maintains | Buy |
05/05/2023 | -4.81% | Barclays | $17 → $18 | Maintains | Equal-Weight |
05/04/2023 | 5.76% | RBC Capital | → $20 | Reiterates | → Outperform |
03/23/2023 | 11.05% | HC Wainwright & Co. | → $21 | Reiterates | → Buy |
03/09/2023 | — | Needham | Initiates Coverage On | → Hold | |
02/24/2023 | 11.05% | HC Wainwright & Co. | $20 → $21 | Maintains | Buy |
02/23/2023 | -10.1% | JP Morgan | $15 → $17 | Maintains | Neutral |
02/23/2023 | 5.76% | Morgan Stanley | $18 → $20 | Maintains | Equal-Weight |
02/23/2023 | 5.76% | RBC Capital | → $20 | Reiterates | → Outperform |
02/15/2023 | 5.76% | RBC Capital | $17 → $20 | Maintains | Outperform |
02/02/2023 | 5.76% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
12/21/2022 | -10.1% | Barclays | → $17 | Initiates Coverage On | → Equal-Weight |
11/23/2022 | -10.1% | Goldman Sachs | $19 → $17 | Maintains | Neutral |
11/03/2022 | -20.68% | JP Morgan | $16 → $15 | Maintains | Neutral |
11/03/2022 | -10.1% | RBC Capital | $18 → $17 | Maintains | Outperform |
11/03/2022 | -4.81% | Morgan Stanley | $19 → $18 | Maintains | Equal-Weight |
11/03/2022 | 5.76% | HC Wainwright & Co. | $21 → $20 | Maintains | Buy |
10/11/2022 | 0.48% | Morgan Stanley | $20 → $19 | Maintains | Equal-Weight |
09/12/2022 | 11.05% | HC Wainwright & Co. | → $21 | Initiates Coverage On | → Buy |
08/16/2022 | 0.48% | Goldman Sachs | $22 → $19 | Maintains | Neutral |
07/26/2022 | 16.34% | RBC Capital | → $22 | Initiates Coverage On | → Outperform |
06/24/2022 | 11.05% | Evercore ISI Group | → $21 | Initiates Coverage On | → Outperform |
06/09/2022 | 5.76% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight |
06/06/2022 | 16.34% | Citigroup | → $22 | Initiates Coverage On | → Buy |
05/31/2022 | 16.34% | Morgan Stanley | → $22 | Initiates Coverage On | → Equal-Weight |
05/31/2022 | 16.34% | Goldman Sachs | → $22 | Initiates Coverage On | → Neutral |
05/31/2022 | 26.92% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
05/31/2022 | 21.63% | Wells Fargo | → $23 | Initiates Coverage On | → Overweight |
05/11/2022 | 85.09% | Cowen & Co. | → $35 | Initiates Coverage On | → Outperform |
What is the target price for Bausch & Lomb (BLCO)?
The latest price target for Bausch & Lomb (NYSE: BLCO) was reported by Barclays on August 3, 2023. The analyst firm set a price target for $19.00 expecting BLCO to rise to within 12 months (a possible 0.48% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bausch & Lomb (BLCO)?
The latest analyst rating for Bausch & Lomb (NYSE: BLCO) was provided by Barclays, and Bausch & Lomb maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Bausch & Lomb (BLCO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bausch & Lomb, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bausch & Lomb was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
Is the Analyst Rating Bausch & Lomb (BLCO) correct?
While ratings are subjective and will change, the latest Bausch & Lomb (BLCO) rating was a maintained with a price target of $18.00 to $19.00. The current price Bausch & Lomb (BLCO) is trading at is $18.91, which is within the analyst's predicted range.